Viremic attack explains the dual-hit theory of Parkinson's disease

Isamu Mori1

  • 1Faculty of Health and Nutrition, Shubun University, Ichinomiya, Aichi 491-0938, Japan.

Medical Hypotheses
|March 30, 2017
PubMed

Insights

Viruses may cause Parkinson's disease by attacking the olfactory and enteric nervous systems simultaneously via viremia. This hypothesis explains the dual-hit theory, paving the way for new Parkinson's disease interventions.

Area of Science:

  • Neuroscience
  • Pathology
  • Virology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder characterized by Lewy pathology.
  • The dual-hit hypothesis suggests PD originates from an airborne pathogen affecting olfactory and enteric nervous systems.
  • Current understanding of PD's initiation mechanisms requires further elucidation.

Purpose of the Study:

  • To propose a novel hypothesis for the dual-hit theory of Parkinson's disease.
  • To explain how viruses could initiate Lewy pathology in both the olfactory and enteric nervous systems simultaneously.
  • To provide a framework for understanding PD neuropathology and developing interventions.

Main Methods:

  • Literature review of published studies on Parkinson's disease and viral infections.
  • Hypothesis formulation based on existing scientific evidence.
  • Analysis of the role of viremia and blood-nerve barriers in neuroinvasion.

Main Results:

  • Viruses with viremic potential can access and infect both the olfactory and enteric nervous systems.
  • The absence of a robust blood-nerve barrier in these tissues facilitates simultaneous viral attack.
  • This simultaneous attack via viremia provides a plausible mechanism for the dual-hit theory of Parkinson's disease.

Conclusions:

  • Viral viremia offers a unifying explanation for the dual-hit hypothesis in Parkinson's disease.
  • Understanding this mechanism can guide the development of targeted prophylactic and early intervention strategies.
  • Further research into viral neuropathogenesis is crucial for combating Parkinson's disease.